"Drug Manufacturing"

#13321345

14 February 2026

The AstraZeneca logo is displayed on the facade of the company's modern office building in Stockholm, Sweden, on May 6, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13321346

14 February 2026

The AstraZeneca logo is displayed on the facade of the company's modern office building in Stockholm, Sweden, on May 6, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293752

9 February 2026

The AstraZeneca logo is displayed on a mobile phone with a stock graph visible in the background in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293753

9 February 2026

The AstraZeneca stock graph is displayed on a mobile phone with AstraZeneca visible in the background in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293754

9 February 2026

The AstraZeneca stock graph is displayed on a mobile phone with AstraZeneca visible in the background in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293755

9 February 2026

The AstraZeneca stock graph is displayed on a mobile phone with AstraZeneca visible in the background in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293756

9 February 2026

The AstraZeneca logo is displayed on a mobile phone with AstraZeneca visible in the background in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293749

9 February 2026

A medical syringe with AstraZeneca visible in the background is seen in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293750

9 February 2026

The AstraZeneca stock graph is displayed on a mobile phone with a stock graph visible in the background in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13293751

9 February 2026

The AstraZeneca logo is displayed on a mobile phone with the AstraZeneca icon visible in the background in this photo illustration in Brussels, Belgium, on February 9, 2026.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13031795

27 November 2025

Calcium channel blocker tablets Diltiazem/Dilzem are unavailable in German pharmacies in Munich, Bavaria, Germany, on November 27, 2025, following delivery problems with statins on the German pharmaceutical market a few weeks ago. Diltiazem is a drug used to treat heart conditions such as angina pectoris (chest pain due to insufficient oxygen supply to the heart muscle) and high blood pressure.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13031797

27 November 2025

Calcium channel blocker tablets Diltiazem/Dilzem are unavailable in German pharmacies in Munich, Bavaria, Germany, on November 27, 2025, following delivery problems with statins on the German pharmaceutical market a few weeks ago. Diltiazem is a drug used to treat heart conditions such as angina pectoris (chest pain due to insufficient oxygen supply to the heart muscle) and high blood pressure.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13031798

27 November 2025

Calcium channel blocker tablets Diltiazem/Dilzem are unavailable in German pharmacies in Munich, Bavaria, Germany, on November 27, 2025, following delivery problems with statins on the German pharmaceutical market a few weeks ago. Diltiazem is a drug used to treat heart conditions such as angina pectoris (chest pain due to insufficient oxygen supply to the heart muscle) and high blood pressure.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12798441

26 September 2025

A general view shows cough syrups at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company builds a manufacturing plant in the U.S.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12798442

26 September 2025

An employee checks medicine at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company builds a manufacturing plant in the U.S.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12798445

26 September 2025

An employee checks medicine at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company builds a manufacturing plant in the U.S.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.